UBS Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,463
Closed -$3.17K 10332
2023
Q1
$3.17K Buy
5,463
+508
+10% +$404 ﹤0.01% 8363
2022
Q4
$3.47K Buy
4,955
+2,158
+77% +$3.51K ﹤0.01% 9508
2022
Q3
$8K Sell
2,797
-690
-20% -$2.61K ﹤0.01% 8804
2022
Q2
$16K Buy
3,487
+1,629
+88% +$7.15K ﹤0.01% 7243
2022
Q1
$13K Sell
1,858
-150
-7% -$871 ﹤0.01% 8112
2021
Q4
$14K Buy
+2,008
New +$20.6K ﹤0.01% 8389
2021
Q3
Sell
-260
Closed -$5K 10389
2021
Q2
$5K Buy
260
+97
+60% +$1.81K ﹤0.01% 8600
2021
Q1
$4K Buy
+163
New +$4.13K ﹤0.01% 8453
2020
Q4
Sell
-112
Closed -$2K 8934
2020
Q3
$2K Sell
112
-156
-58% -$2.93K ﹤0.01% 7717
2020
Q2
$4K Sell
268
-307
-53% -$4.79K ﹤0.01% 7495
2020
Q1
$8K Sell
575
-33
-5% -$670 ﹤0.01% 7103
2019
Q4
$18K Sell
608
-202
-25% -$4.83K ﹤0.01% 6954
2019
Q3
$13K Buy
810
+247
+44% +$4.81K ﹤0.01% 7018
2019
Q2
$14K Buy
563
+561
+28,050% +$17.5K ﹤0.01% 6866
2019
Q1
$0 Sell
2
-126
-98% -$5.18K ﹤0.01% 8327
2018
Q4
$5K Buy
128
+102
+392% +$8.6K ﹤0.01% 7578
2018
Q3
$4K Sell
26
-31
-54% -$4.59K ﹤0.01% 7597
2018
Q2
$7K Sell
57
-349
-86% -$52.8K ﹤0.01% 7363
2018
Q1
$100K Sell
406
-624
-61% -$176K ﹤0.01% 5223
2017
Q4
$285K Sell
1,030
-830
-45% -$317K ﹤0.01% 4668
2017
Q3
$753K Buy
1,860
+491
+36% +$256K ﹤0.01% 3926
2017
Q2
$811K Buy
1,369
+1,367
+68,350% +$799K ﹤0.01% 3786
2017
Q1
$1K Sell
2
-3
-60% -$1.07K ﹤0.01% 7490
2016
Q4
$1K Sell
5
-6
-55% -$1.36K ﹤0.01% 7664
2016
Q3
$3K Hold
11
﹤0.01% 7322
2016
Q2
$3K Sell
11
-72
-87% -$25.3K ﹤0.01% 7357
2016
Q1
$36K Buy
83
+4
+5% +$1.5K ﹤0.01% 5753
2015
Q4
$39K Buy
79
+14
+22% +$10.1K ﹤0.01% 6066
2015
Q3
$77K Buy
65
+50
+333% +$76.6K ﹤0.01% 5449
2015
Q2
$26K Buy
15
+6
+67% +$9.33K ﹤0.01% 6632
2015
Q1
$11K Sell
9
-32
-78% -$37.9K ﹤0.01% 7586
2014
Q4
$41K Buy
+41
New +$41.1K ﹤0.01% 6741

Other funds holding VYNT